Resources

Research HighlightExplore our latest publication in Allergy: the story behind the idea and key findings.The landscape of vaccine research is undergoing an important transformation, thanks to the breakthroughs in mRNA vaccine technology. This innovation has catalyzed the development of vaccines that are not only highly effective but also rapidly deployable at a large scale. With the increasing number of researchRead more

In this white paper, discover new validation data demonstrating the stability, injectability and immunocompetency of our HypoSkin^® model.

Mast CellsSingle-cell profiling of biostabilized natural human skin identifies mast cells as an important target of injected mRNA-1273 COVID-19 vaccine. Research by M. Scholaert1,2, M. Peries2, E. Braun2, J. Martin1, N. Serhan1, A. Loste1, A. Bruner1, L. Basso1, E. Merle2, A. Trevisiol2, E. Pagès2 and N. Gaudenzio1,2 1Toulouse Insitute for Infectious and Inflammatory Diseases (Infinity), 2Genoskin The field of vaccinationRead more

Skin MicrobiomeA fully functional ex vivo human skin model to study human skin microbiome Research by B. Coupe1, M. Pastore2, E. Pagès2, E. Braun2, A. Broha1, P. Descargues2 1Vaiomer, 2Genoskin The human skin is colonized by a diverse population of microorganisms. The symbiotic host-microorganism relationship can be affected by numerous endogenous and exogenous factors. This can result in skin disordersRead more

Genoskin presents WoundSkin^®, an infected wounded ex vivo skin model suited to assess the efficacy of wound-healing formulations.

Skin ModelsPreservation of human skin integrity and metabolism during 10 days in culture with NativeSkin® system Research by E. Raude1, E. Pagès1, M. Pastore1, P.-O. Cuoc2, L. Malaquin3, P. Descargues1 1Genoskin, 2Promega, 3LAAS-CNRS Scientific Context Human epidermis is not vascularized and oxygen only reaches epidermal cells by diffusing through the stratum corneum or from the dermal papillae which contains aRead more